Notably, G6PD, FASN and LPIN1 are upregulated in HCC compared with non-tumor livers in both HCC cohorts (Supplementary Table 9) while ETFDH is downregulated (Fig. S7D), highlighting the likely role of lipid metabolism and PPP pathways in liver cancer. The gene discussed is LPIN1; the disease is liver cancer.